Marshall Wace »

Arrivent Biopharma shares owned by Marshall Wace

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-09-30 $2.0M 85k 23.50

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Spdr S&p 500 Etf Equity Option Call Option (SPY)
Microsoft Corp Common Stock (MSFT)
Amazon.com Equity Option Put Option (AMZN)
Apple Common Stock (AAPL)
Meta Platforms-a Common Stock (META)
Nvidia Corp Common Stock (NVDA)
Alphabet Inc-a Common Stock (GOOGL)
Tesla Common Stock (TSLA)
Flutter Enter-di Common Stock (FLUT)
Johnson&johnson Common Stock (JNJ)
Eli Lilly & Co Common Stock (LLY)
Boston Scientifc Common Stock (BSX)
Broadcom Common Stock (AVGO)
Spdr Gold Trust Equity Option Call Option (GLD)

View all positions for Marshall Wace

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
BlackRock
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Geode Capital Management
Cormorant Asset Management
Perceptive Advisors
Northern Trust

View all funds holding Arrivent Biopharma